TrialImmunoTargets and therapy2026

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

Sebastian Meltzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.